How a new pill could reduce asthma attacks
The drug Fevipiprant improves air flow to the lungs by removing muscle in the airway lining, a study has shown
Scientists from the University of Leicester have successfully trialled a new pill that reduces asthma attacks by targeting airway muscles.
The experimental drug Fevipiprant “is the first oral treatment for asthma in 20 years”, says the Press Association.
The new study shows that the drug works by reducing the amount of muscle in the airway lining. Previous trials had shown that it improves breathing, reduces inflammation and helps to repair the lining of patients’ airways but the new study is the first to show exactly how it does it.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Professor Chris Brightling, from the University of Leicester, said: “Our research shows for the first time that Fevipiprant not only reduces inflammation in the airways, but also reduces the amount of muscle in the lining of the airway. This is likely to explain some of the effects seen in the symptoms and breathing tests following treatment.”
He added: “Our findings suggest that Fevipiprant could have positive long-term effects upon the progression of the disease through remodelling, as well as improve symptoms and reduce attacks.”
The asthma drug “specifically blocks the activation of a muscle protein, which reduces the movement of the immature muscle cells from forming a bundle and blocking the airway”, says Sky News.
There are more than 300 million people who are affected by asthma worldwide and the number is increasing. In the UK there are roughly around 500,000 people who have moderate to severe forms of asthma.
Currently “there are no drugs available on the NHS which treat the build-up of smooth muscle mass as a method of reducing asthma symptoms”, adds Sky News.
For people with severe asthma, “a procedure called thermoplasty, which uses thermal energy to decrease the amount of smooth muscle in the airways, may be offered”, says Medical Xpress. This requires “sedation in hospital and is not a cure, nor suitable for everyone”, the website adds.
Most people in the UK affected by asthma are able to routinely manage the condition with inhaled drugs and steroids.
But Fevipiprant could offer sufferers a way to avoid some of the side-effects associated with using steroids including weight gain.
Dr Himanshu Kaul, a postdoctoral fellow in the School of Biomedical Engineering at the University of British Columbia who helped with the trial, said: "Our computer model represents a milestone towards patient-specific models in respiratory medicine that has the potential to help design new drugs and optimise existing therapies."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
Tianeptine: why lawmakers fear a new kind of opioid
The explainer The drug is sold over the counter. And is highly addictive.
By Devika Rao, The Week US Published
-
The pros and cons of compounding pharmacies
Pros and cons Customizing medications can be lifesaving and also dangerous
By Devika Rao, The Week US Published
-
How polysubstance abuse is worsening the American opioid crisis
The Explainer Studies are showing that more Americans are struggling with dependency on multiple substances.
By Theara Coleman, The Week US Published
-
Kush: the drug destroying young lives in West Africa
The Explainer There has been a sharp rise in young addicts in Sierra Leone, Guinea and Liberia
By Flora Neville, The Week UK Published
-
Magic mushrooms and the mind
The Explainer A growing number of states and cities are legalizing the use of psychedelic fungi in therapy. Some experts think that’s a big risk.
By The Week US Published
-
Marijuana use associated with heart attack and stroke
Speed Read Two new studies point to an increased risk of cardiovascular problems
By Devika Rao, The Week US Published